Novo Nordisk said the side effects in trials so far for its experimental obesity drug CagriSema were similar to its GLP-1 ...

Analysts have struggled to estimate the size of the compounded market for weight-loss drugs because their sale is not tracked ...

Novo Nordisk (NVO), the maker of blockbuster weight-loss and diabetes drugs Wegovy and Ozempic, has entered an agreement with ...

Leigh-Anne Lagden was given a free weight loss injection in exchange for social media promotion but claims they told her to ...

“I’m playing doctor,” Bookless said, describing her foray into the world of do-it-yourself GLP-1 medication, injections ...

Munjaro and Ozempic have emerged as useful tools for weight loss, particularly for people dealing with obesity or type 2 ...

Novo Nordisk chief financial officer Karsten Munk Knudsen said on Wednesday the company was aware of reports of 10 deaths and ...

There’s been lots of attention on type 2 diabetes drugs recently, especially since they might also be able to support weight ...

As weight-loss injections emerge as key players in the government’s anti-obesity strategy, Emma Loffhagen goes inside the ...

The U.S. Food and Drug Administration on Friday warned patients and health care professionals not to use compounded drugs, ...

In a concerning trend, an increasing number of individuals in the Gulf region are turning to weight loss injections as a ...